Nath Bio-Genes Reports Record Sales and Profit Amid Rising Interest Expenses in July 2025

Nath Bio-Genes (India), a microcap company in the Other Agricultural Products industry, has recently reported its financial results for the quarter ending June 2025. The results, declared on July 11, 2025, indicate a stable financial performance during this period. The company achieved its highest net sales in the last five quarters, reaching Rs 283.70 crore. This positive trend is mirrored in its operating profit, which also peaked at Rs 38.29 crore. Additionally, profit before tax (PBT) and profit after tax (PAT) both reached their highest levels in the same timeframe, at Rs 34.12 crore and Rs 37.28 crore, respectively. Earnings per share (EPS) have also shown a notable increase, standing at Rs 19.62, reflecting enhanced profitability for shareholders. Furthermore, the debtors turnover ratio improved to 4.10 times, indicating a more efficient collection process. However, the financial results also highlight a significant rise in interest expenses, which grew by 133.58% quarter on quarter, suggesting an increase in borrowings. In light of these developments, Nath Bio-Genes has experienced adjustments in its evaluation, with its score moving to 3 from -15 over the past three months. Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.